Novel phenotype of achondroplasia due to biallelicFGFR3pathogenic variants

Authors:

Abstract
Pathogenic variants in the fibroblast growth factor receptor 3 (FGFR3) gene are responsible for a broad spectrum of skeletal dysplasias, including achondroplasia (ACH). The classic phenotype of ACH is caused by two highly prevalent mutations, c.1138G > A and c.1138G > C (p.Gly380Arg). In the homozygous state, these variant results in a severe skeletal dysplasia, neurologic deficits, and early demise from respiratory insufficiency. Although homozygous biallelic mutations have been reported in patients with ACH in combination with hypochondroplasia or other dominant skeletal dysplasias, thus far, no cases of heterozygous biallelic pathogenic ACH‐related variants inFGFR3have been reported. We describe a novel phenotype of an infant with two ACH‐related mutations inFGFR3, p.Gly380Arg and p.Ser344Cys. Discordant features from classic ACH include atypical radiographic findings, severe obstructive sleep apnea, and focal, migrating seizures. We also report the long‐term clinical course of her father, who harbors the p.Ser344Cys mutation that has only been reported once previously in a Japanese patient. The phenotype of heterozygous biallelic mutations inFGFR3associated with ACH is variable, underscoring the importance of recognition and accurate diagnosis to ensure appropriate management.
Funding Information
  • National Institutes of Health (T32GM007454)
  • Clinical Center

This publication has 31 references indexed in Scilit: